Upcoming projects

​We are currently working on starting several new research projects. 

Precision Brain-Circuit Therapy (Precision-BCT):

CNDR is to be a partner in a research project at Hvidorvre Hospital, where the goal is to develop and commercialize a stimulation-based, personalized precision brain circuit (Precision-BCT) therapy for major depression.
The project is funded by the Innovation Fund.

Supervisor: Poul Videbech

​BrainDrugs - Neuropharmacological treatment: Precision medicine in epilepsy and depression:

CNDR will collaborate with Professor Gitte Moos Knudsen, Institute Neurobiology Research Unit Department Department of Neurology, Rigshospitalet, regarding a research project aimed at ensuring that patients with epilepsy or depression receive a treatment that is better tailored to their needs. The project is funded by the Lundbeck Foundation.

Supervisor: Poul Videbech


CNDR will collaborate with Foulum in a 4-year project concerning use of therapy animals. The project consists of two parts, with CNDR participating in the second part, consisting of two case studies - one with nursing home residents and one with war veterans. CNDR participates in the case study on war veterans, where they will examine the effect of a service dog's presence on war veterans with PTSD - both in challenging and non-challenging situations - ie. with high and low stress loads. The project is funded by the Trygfonden.

In addition, it is expected that the CNDR and the Psychiatric Center Glostrup will participate in the following projects:
Psychiatric Center Glostrup is expected to participate in the nationwide multicentre project: “Transcranial low voltage pulsed electromagnetic fields (T-PEMF) for treatment resistant bipolar depression: a randomized, sham-controlled, multicenter study (the 9th study from the Danish University Antidepressant Group, DUAG -9) ". The program is a collaboration between psychiatric departments in the university cities and directed by from Aalborg University Hospital.
In addition, Psychiatric Center Glostrup is expected to participate in the multinational multicentre project: "Esketamine nasal spray in Treatment Resistant Depression: a phase IIIb study". Professor Poul Videbech is expected to lead the project at the Psychiatric Center Glostrup.

Responsible editor